Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Marc C. Gittelman, M.D.
EIR
•Marc C. Gittelman, M.D.•August 26, 2021

Marc C. Gittelman, M.D. – FDA EIR, Aug 26, 2021

Record Details

An FDA inspection of Marc C. Gittelman, M.D., operating as South Florida Medical Research in Aventura, FL, was conducted from August 17-26, 2021. This was a high-priority, for-cause inspection focusing on a specific human drug clinical trial. The inspection, conducted under Compliance Programs 7348.003 and 7348.811, aimed to ensure compliance with regulatory requirements for clinical investigators and bioavailability/bioequivalence studies. The main violation identified, documented on a Form FDA 483, was the failure to prepare or maintain accurate case histories regarding observations and data pertinent to the investigation, specifically referencing 21 CFR 312.62(b). The core issue was inadequate documentation of laboratory sample processing. For five reviewed subjects, there was no record to confirm that critical procedures outlined in the Central Laboratory Manual were followed. These procedures included specific instructions for blood collection tube mixing, allowing samples to stand in a controlled environment for a defined duration, and maintaining appropriate temperature conditions until shipment. An internal investigation by the Contract Research Organization corroborated several deviations from these protocol-specific sample handling requirements. In response, Dr. Marc C. Gittelman acknowledged the findings on the Form FDA 483 and agreed to submit a written response detailing corrective actions within 15 business days. A verbal warning was also issued regarding the importance of adhering to all regulatory requirements.

Company
Marc C. Gittelman, M.D.
Inspection date
August 26, 2021
Product type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Craig A. Garmendia (investigator)
  • Amy Gittelman (company_representative)
  • Marc C. Gittelman (investigator)
View Company Profile

ID · 11298571-d6a0-4131-bba2-27e4ad9b1c24

Violation Codes1
21 CFR 312.62(b)

Full citation text and observation details available on the Dashboard.

Other documents for Marc C. Gittelman, M.D.
  • 483 - 2021-08-26August 26, 2021

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Marc C. Gittelman, M.D.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.